Alessandro Leonetti

机构：University of Parma, University Hospitals Parma Medical Center · ORCID：0000-0001-5415-6703

发表论文 174 篇 · 总被引 3651 次 · h-index 26

代表论文

• Liquid Biopsy Monitoring in BRAF V600E–Mutated Patients With Non–Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020) (2026 · JCO Precision Oncology · 被引 1)
• Data from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib (2026)
• Supplementary Tables1 from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib (2026)
• Supplementary Figures1 from Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non–Small Cell Lung Cancer Receiving First-line Osimertinib (2026)
• The Tumor Microenvironment in Non-Small Cell Lung Cancer Brain Metastases: Composition, Dynamics, and Therapeutic Implications (2026 · Cancer Biome and Targeted Therapy)
• PP01.01: Genomic Determinants of Acquired Resistance to BRAF/MEK Inhibitors in BRAF V600E-Mutant Non-Small Cell Lung Cancer (2026 · Journal of Thoracic Oncology)